"This is a landmark event for children suffering from terminal heart failure." Charles D. Fraser, Jr., MD, Texas Children’s Hospital THE WOODLANDS, Tex., and BERLIN, Dec. 16, 2011—The Berlin Heart ...

GREENVILLE, N.C. (WITN) - ECU Health’s Ventricular Assist Device (VAD) program has officially served the Eastern Carolina community for seven years. “I never thought I’d probably hit seven years, you ...

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

Patients have the right to refuse or request the withdrawal of any unwanted treatment. In a new article, experts explore the legal and ethical permissibility of carrying out such a request specific to ...

September 21, 2010 (Boston, Massachusetts) — Despite advances in the design of ventricular assist devices (VAD) for patients with advanced heart failure, infections continue to be a major problem and ...

NEW ORLEANS, Nov. 9 - A heart ventricular assist device (VAD) is used as a bridge to organ transplantation, maintaining a patient's cardiac function until a donor organ becomes available. In some ...

After receiving only the fourth US implant of a new-generation, Utah-made ventricular assist device, an Idaho man with heart failure is looking forward to resuming an active life following an ...

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.

The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...

Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...

The global ventricular assist devices (VAD) market is projected to grow at a CAGR of ~11% during the forecast period. This growth is primarily driven by the rising prevalence of heart failure, the ...